Cargando…

C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads

BACKGROUND: C-arm computed tomography (CT) guided intervention is an increasingly applied technique in transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC). The aim of this study was to analyse the value of parenchymal blood volume (PBV) maps acquired during C-arm CT acquisition,...

Descripción completa

Detalles Bibliográficos
Autores principales: Syha, Roland, Grözinger, Gerd, Grosse, Ulrich, Maurer, Michael, Zender, Lars, Horger, Marius, Nikolaou, Konstantin, Ketelsen, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696182/
https://www.ncbi.nlm.nih.gov/pubmed/26715200
http://dx.doi.org/10.1186/s40644-015-0057-x
_version_ 1782407744408518656
author Syha, Roland
Grözinger, Gerd
Grosse, Ulrich
Maurer, Michael
Zender, Lars
Horger, Marius
Nikolaou, Konstantin
Ketelsen, Dominik
author_facet Syha, Roland
Grözinger, Gerd
Grosse, Ulrich
Maurer, Michael
Zender, Lars
Horger, Marius
Nikolaou, Konstantin
Ketelsen, Dominik
author_sort Syha, Roland
collection PubMed
description BACKGROUND: C-arm computed tomography (CT) guided intervention is an increasingly applied technique in transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC). The aim of this study was to analyse the value of parenchymal blood volume (PBV) maps acquired during C-arm CT acquisition, for pre-treatment evaluation and planning of TACE in HCC patients. METHODS: A total of 64 HCC lesions in 29 patients (median age, 73 years, range, 62–77 years) were included in this retrospective study. All patients received cross-sectional imaging (MRI or CT) prior to TACE and C-arm CT PBV measurement acquisition before performing TACE. Results of cross-sectional imaging regarding the number of HCC lesions and maximum diameter were compared to PBV–maps. Number of lesions and tumour feeding vessels detected in PBV-maps were compared to conventional angiography. Results of PBV were analysed concerning different tumour morphologies (pre-treated, encapsulated and diffuse). RESULTS: Pre-interventional cross-sectional imaging and PBV maps showed an excellent agreement in lesion diameter (p = 0.88, MD = −0.28 mm) and number of detected lesions (κ = 1.0). Compared to conventional angiography, PBV maps showed an increased number of detected lesions (κ = 0.77, p = 0.001) and tumour feeding vessels (κ = 0.71, p < 0.0001). Diffuse HCC lesion revealed a significantly lower PBV compared to encapsulated lesions (p = 0.0001). CONCLUSIONS: C-arm CT acquired PBV measurements detect HCC tumours with a lesion detectability comparable to pre-interventional cross-sectional imaging. Furthermore, this technique facilitates TACE, allowing a more precise localization of HCC lesions and tumour feeding vessels compared to conventional angiography. Additionally, calculated PBV values enable a real time quantitative assessment of tumour perfusion.
format Online
Article
Text
id pubmed-4696182
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46961822015-12-31 C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads Syha, Roland Grözinger, Gerd Grosse, Ulrich Maurer, Michael Zender, Lars Horger, Marius Nikolaou, Konstantin Ketelsen, Dominik Cancer Imaging Research Article BACKGROUND: C-arm computed tomography (CT) guided intervention is an increasingly applied technique in transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC). The aim of this study was to analyse the value of parenchymal blood volume (PBV) maps acquired during C-arm CT acquisition, for pre-treatment evaluation and planning of TACE in HCC patients. METHODS: A total of 64 HCC lesions in 29 patients (median age, 73 years, range, 62–77 years) were included in this retrospective study. All patients received cross-sectional imaging (MRI or CT) prior to TACE and C-arm CT PBV measurement acquisition before performing TACE. Results of cross-sectional imaging regarding the number of HCC lesions and maximum diameter were compared to PBV–maps. Number of lesions and tumour feeding vessels detected in PBV-maps were compared to conventional angiography. Results of PBV were analysed concerning different tumour morphologies (pre-treated, encapsulated and diffuse). RESULTS: Pre-interventional cross-sectional imaging and PBV maps showed an excellent agreement in lesion diameter (p = 0.88, MD = −0.28 mm) and number of detected lesions (κ = 1.0). Compared to conventional angiography, PBV maps showed an increased number of detected lesions (κ = 0.77, p = 0.001) and tumour feeding vessels (κ = 0.71, p < 0.0001). Diffuse HCC lesion revealed a significantly lower PBV compared to encapsulated lesions (p = 0.0001). CONCLUSIONS: C-arm CT acquired PBV measurements detect HCC tumours with a lesion detectability comparable to pre-interventional cross-sectional imaging. Furthermore, this technique facilitates TACE, allowing a more precise localization of HCC lesions and tumour feeding vessels compared to conventional angiography. Additionally, calculated PBV values enable a real time quantitative assessment of tumour perfusion. BioMed Central 2015-12-29 /pmc/articles/PMC4696182/ /pubmed/26715200 http://dx.doi.org/10.1186/s40644-015-0057-x Text en © Syha et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Syha, Roland
Grözinger, Gerd
Grosse, Ulrich
Maurer, Michael
Zender, Lars
Horger, Marius
Nikolaou, Konstantin
Ketelsen, Dominik
C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads
title C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads
title_full C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads
title_fullStr C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads
title_full_unstemmed C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads
title_short C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads
title_sort c-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696182/
https://www.ncbi.nlm.nih.gov/pubmed/26715200
http://dx.doi.org/10.1186/s40644-015-0057-x
work_keys_str_mv AT syharoland carmcomputedtomographyparenchymalbloodvolumemeasurementinevaluationofhepatocellularcarcinomabeforetransarterialchemoembolizationwithdrugelutingbeads
AT grozingergerd carmcomputedtomographyparenchymalbloodvolumemeasurementinevaluationofhepatocellularcarcinomabeforetransarterialchemoembolizationwithdrugelutingbeads
AT grosseulrich carmcomputedtomographyparenchymalbloodvolumemeasurementinevaluationofhepatocellularcarcinomabeforetransarterialchemoembolizationwithdrugelutingbeads
AT maurermichael carmcomputedtomographyparenchymalbloodvolumemeasurementinevaluationofhepatocellularcarcinomabeforetransarterialchemoembolizationwithdrugelutingbeads
AT zenderlars carmcomputedtomographyparenchymalbloodvolumemeasurementinevaluationofhepatocellularcarcinomabeforetransarterialchemoembolizationwithdrugelutingbeads
AT horgermarius carmcomputedtomographyparenchymalbloodvolumemeasurementinevaluationofhepatocellularcarcinomabeforetransarterialchemoembolizationwithdrugelutingbeads
AT nikolaoukonstantin carmcomputedtomographyparenchymalbloodvolumemeasurementinevaluationofhepatocellularcarcinomabeforetransarterialchemoembolizationwithdrugelutingbeads
AT ketelsendominik carmcomputedtomographyparenchymalbloodvolumemeasurementinevaluationofhepatocellularcarcinomabeforetransarterialchemoembolizationwithdrugelutingbeads